Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 19,300 shares, an increase of 58.2% from the April 30th total of 12,200 shares. Currently, 1.4% of the shares of the company are short sold. Based on an average trading volume of 10,000 shares, the short-interest ratio is currently 1.9 days.

Arcadia Biosciences Price Performance

Shares of RKDA opened at $4.59 on Tuesday. The firm has a 50-day moving average of $3.56 and a 200-day moving average of $4.20. Arcadia Biosciences has a one year low of $2.40 and a one year high of $10.31. The company has a market cap of $6.28 million, a PE ratio of -1.07 and a beta of 0.35.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings data on Thursday, May 8th. The basic materials company reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of ($0.98) by $2.88. Arcadia Biosciences had a negative net margin of 110.61% and a negative return on equity of 52.63%. The company had revenue of $1.20 million during the quarter, compared to the consensus estimate of $1.60 million.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences as of its most recent filing with the Securities and Exchange Commission. 17.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen started coverage on shares of Arcadia Biosciences in a research report on Sunday, May 18th. They issued a “sell” rating for the company.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.